Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-03-15
著者
-
Noto Shun
Stem Cell Transplantation Center Hokkaido University Hospital
-
Endo Tomoyuki
Stem Cell Transplantation Center Hokkaido University Hospital
-
Asano S
Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Asano Shigetaka
東京大学医科学研究所 血液腫瘍内科
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Tanaka J
Stem Cell Transplantation Center Hokkaido University Hospital
-
Asano Shigetaka
Institute Of Medical Science University Of Tokyo
-
Asano Shigetaka
Department Of Pediatric Hematology/oncology The Institute Of Medical Science The University Of Tokyo
-
Onozawa Masahiro
Stem Cell Transplantation Center Hokkaido University Hospital
-
Nishio Mitsufumi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Kondo Takeshi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Asaka Masahiro
Department Of Gastroenterology And Hematology Hokkaido University Graduate School Of Medicine
-
Hashino Satoshi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Takahata Mutsumi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Imamura M
Stem Cell Transplantation Center Hokkaido University Hospital
-
Koike Takao
Department Of Medicine Ii Hokkaido University Graduate School Of Medicine
-
Takeda Yukari
Stem Cell Transplantation Center Hokkaido University Hospital
-
YASUMOTO Atsushi
Stem Cell Transplantation Center, Hokkaido University Hospital
-
ARITA Kotaro
Stem Cell Transplantation Center, Hokkaido University Hospital
-
SUGITA Jun-ichi
Stem Cell Transplantation Center, Hokkaido University Hospital
-
SHIGEMATSU Akio
Stem Cell Transplantation Center, Hokkaido University Hospital
-
OKADA Kohei
Stem Cell Transplantation Center, Hokkaido University Hospital
-
KAHATA Kaoru
Stem Cell Transplantation Center, Hokkaido University Hospital
-
OBARA Masato
Stem Cell Transplantation Center, Hokkaido University Hospital
-
YAMAMOTO Satoshi
Stem Cell Transplantation Center, Hokkaido University Hospital
-
SATO Norihiro
Stem Cell Transplantation Center, Hokkaido University Hospital
-
TANAKA Junji
Stem Cell Transplantation Center, Hokkaido University Hospital
-
IMAMURA Masahiro
Stem Cell Transplantation Center, Hokkaido University Hospital
-
Asaka Masahiro
Third Department Of Internal Medicine Hokkaido University Graduate School Of Medicine
-
Kawamura Takahito
Department Of Medicine Ii Hokkaido University Graduate School Of Medicine
-
Maruta Ichiroh
Department Of Hematology And Oncology Hokkaido University Graduate School Of Medicine
-
Sato Norihiro
Translational Research And Clinical Trial Center Hokkaido University Hospital
-
Tanaka Junji
Stem Cell Transplantation Center Hokkaido University Hospital
-
Shigematsu Akio
Stem Cell Transplantation Center Hokkaido University Hospital
-
Imamura Masahiro
Department Of Internal Medicine Saiseikai-hita Hospital
-
Kahata Kaoru
Stem Cell Transplantation Center Hokkaido University Hospital
-
Koike Takao
Department Of Internal Medicine Ii School Of Medicine Hokkaido University
-
Kondo Takeshi
北海道大学 医学研究科消化器内科学
-
Onozawa Masahiro
北海道大学 医学研究科消化器内科学
-
Takeuchi Jin
First Department Of Internal Medicine Nihon University School Of Medicine
-
Obara Masato
Department Of Internal Medicine Ii Hokkaido University Graduate School Of Medicine
-
Okada Kohei
Stem Cell Transplantation Center Hokkaido University Hospital
-
Arita Kotaro
Stem Cell Transplantation Center Hokkaido University Hospital
-
Iwahashi Masahiro
Department Of Internal Medicine Saiseikai-hita Hospital
-
Asaka Masahiro
Hokkaido Univ. School Of Medicine Sapporo Jpn
-
Kondo Takeshi
Department Of Medicine Ii Hokkaido University Graduate School Of Medicine
-
Imamura M
Department Of Internal Medicine Saiseikai-hita Hospital
-
Kondo Takeshi
Department Of Gastroenterology And Hematology Hokkaido University Graduate School Of Medicine
-
Shimoyama Norihiko
Department Of Clinical Pathology Hakodate Municipal Hospital
-
Yasumoto Atsushi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Tanaka Junji
Japan Society For Hematopoietic Cell Transplantation Adult Data Management Committee
-
Koike Takao
Department Of Internal Medicine Hokkaido University School Of Medicine
-
Yamamoto Satoshi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Asaka M
Department Of Gastroenterology Hokkaido University Graduate School Of Medicine
-
Sugita Junichi
Stem Cell Transplantation Center Hokkaido University Hospital
-
Kondo Takeshi
Department Of Pathology Laboratory Of Cancer Research Hokkaido University Graduate School Of Medicine
-
Tanaka Shinya
Department Of Pathology Laboratory Of Cancer Research Hokkaido University Graduate School Of Medicine
-
Asaka Masahiro
Department Of Cancer Preventive Medicine Graduate School Of Medicine Hokkaido University
-
KOIKE Takao
Department II, Hokkaido University Graduate School of Medicine
関連論文
- DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
- Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation : a case report
- Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Bacterial Bloodstream Infection in Neutropenic Adult Patients after Myeloablative Cord Blood Transplantation : Experience of a Single Institution in Japan
- Pancreatic Hyperamylasemia and Hyperlipasemia in Association with Cytomegalovirus Infection following Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia
- Posttransplantation Engraftment and Safety of Cord Blood Transplantation with Grafts Containing Relatively Low Cell Doses in Adults
- Hemorrhagic Cystitis in Adults after Unrelated Cord Blood Transplantation : A Single-Institution Experience in Japan
- Varicella-Zoster Virus Encephalitis in a Patient Undergoing Unrelated Cord Blood Transplantation for Myelodysplastic Syndrome-Overt Leukemia
- Early-Onset Thyrotoxicosis after Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia
- Atypical Hypersensitivity to Mosquito Bites without Natural Killer Cell Proliferative Disease in an Adult Patient
- Unrelated Cord Blood Transplantation after Myeloablative Conditioning for Adult Patients with Refractory Anemia
- Human Herpesvirus 6 Variant B Infection in Adult Patients after Unrelated Cord Blood Transplantation
- Unrelated Cord Blood Transplantation with a Reduced-Intensity Conditioning Regimen following Autologous Transplantation for Multiple Myeloma
- Acute Myelogenous Leukemia M5b Developed during Clinical Remission of Castleman Disease
- Using Related Donors Other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease : A Single Institution Experience in Japan
- Severe Immune Dysfunction after Lethal Neutron Irradiation in a JCO Nuclear Facility Accident Victim
- Second Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia Relapse After First Allogeneic Transplantation : Outcome of 16 Patients in a Single Institution
- Severe Autoimmune Thrombocytopenia After Allogeneic Bone Marrow Transplantation for Aplastic Anemia
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study Group
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Hematopoietic Capability of CD34^+ Cord Blood Cells: A Comparison With CD34^+ Adult Bone Marrow Cells
- Glycoprotein 130 and c-kit Signals Synergistically Induce Thrombopietin Production by Hematopoietic Cells
- Analysis of 20-Year Follow-up Study of LVP Regimen for Adult Acute Lymphoblastic Leukemia
- Long-term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase
- Refractory Facial Cellulitis Following Cosmetic Rhinoplasty After Cord-blood Stem Cell Transplantation
- Preparative and Clinical Studies of Immunogene Therapy Using Autologous GM-CSF Transduced Tumor Vaccines for Stage IV Renal Cell Cancer
- CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis
- Establishment of novel cell lines derived form two patients with chronic myelogenous leukemia in blast crisis; IMS-BC1 and IMS-BC2 which exhibit markedly different sensitivity to apoptosis
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Advanced renal cell carcinoma treated with granulocytemacrophage colony-stimulating factor gene therapy : A clinical course of the first Japanese experience
- Usefulness of magnifying endoscopic evaluation of the terminal ileum for a patient with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- Proliferation of CD4^+ Lymphocytes in a Patient With Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation
- Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation
- Cord blood transplantation with a reduced-intensity conditioning regimen for patients with relapsed aggressive multiple myeloma after cytoreduction with bortezomib
- Regimen-Related Mucosal Injury of the Gut Increased the Incidence of CMV Disease after Allogeneic Bone Marrow Transplantation
- Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease.
- Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin
- Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia
- Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells
- Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma
- Ciprofloxacin inhibits lipopolysaccharide-induced toll-like receptor-4 and 8 expression on human monocytes derived from adult and cord blood
- Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients
- A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance
- Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia
- Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation
- HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV Infection
- Efficacy and safety of Micafungin in Febrile NeutropenicPatients Treated for Hematological Malignancies
- Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
- Aleukemic leukemia cutis in a patient with Philadelphia chromosome-positive biphenotypic leukemia.
- HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level : a retrospective analysis in one institution
- A Case of Non-Hodgkin's Lymphoma and Invasive Thymoma Treated with R-CHOP Therapy
- Successful Reduced-intensity Stem Cell Transplantation (RIST) for a Patient with Malignant Lymphoma and an Ileostomy
- Potential Role of Natural Killer Cell Receptor-Expressing Cells in Immunotherapy for Leukemia
- Successful Micafungin (FK463) Treatment of Invasive Pulmonary Aspergillosis in a Patient with Acute Lymphoblastic Leukemia in a Phase II Study
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Rhabdomyolysis Caused by Distigmine Bromide
- Allogeneic Bone Marrow Transplantation as a Therapeutic Modality for Hematological Disorders : A Report Based on 39 Cases
- Treatment With Low-Dose Cytosine Arabinoside Followed by Administration of Macrophage Colony-Stimulating Factor Prolongs the Survival of Patients With RAEB, RAEB-T, or Leukemic Phase Myelodysplastic Syndrome: A Pilot Study
- Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia
- CARDIOTOXICITY IN HIGH-DOSE CHEMOTHERAPY FOLLOWED BY BONE MARROW TRANSPLANTATION : THE EVALUATION OF LEFT VENTRICULAR FUNCTION
- ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses
- A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells
- Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system
- Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation
- Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
- Positive Expression of Macrophage Inflammatory Protein-1α and -1β in a Patient with Diffuse Large B-cell Lymphoma Accompanied by Hypercalcemia and Multiple Osteolysis
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the Lymphoma Treatment Study Group in Japan
- Donor cell leukemia after umbilical cord blood transplantation : recurrent or de novo? The importance of diagnosis for therapeutic decision making
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment of Hodgkin lymphoma in second trimester of pregnancy : feasibility of ABVD regimen
- An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma
- Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia
- Expansion of CD4+CD25+ regulatory T cells from cord blood CD4+ cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin
- Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids : who should be given prophylaxis?
- A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations
- HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine
- Current status of hematopoietic stem cell transplantation for acute radiation syndromes